HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John H Ansede Selected Research

N- methoxy- 6- (5- (4- (N- methoxyamidino)phenyl)furan- 2- yl)nicotinamidine

1/2014CYP1A1 and CYP1B1-mediated biotransformation of the antitrypanosomal methamidoxime prodrug DB844 forms novel metabolites through intramolecular rearrangement.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John H Ansede Research Topics

Disease

1Hyperkalemia
06/2014
1Cystic Fibrosis (Mucoviscidosis)
06/2014
1Lung Diseases (Lung Disease)
02/2014
1African Trypanosomiasis (Nagana)
01/2014
1Cholestasis
02/2010
1Infections
08/2004

Drug/Important Bio-Agent (IBA)

3Pharmaceutical PreparationsIBA
06/2014 - 02/2010
2ProdrugsIBA
01/2014 - 08/2004
1SodiumIBA
06/2014
1PotassiumIBA
06/2014
1Epithelial Sodium ChannelsIBA
06/2014
1N- methoxy- 6- (5- (4- (N- methoxyamidino)phenyl)furan- 2- yl)nicotinamidineIBA
01/2014
1furanIBA
01/2014
1Bile Acids and Salts (Bile Acids)IBA
02/2010
1furamidine (DB75)IBA
08/2004

Therapy/Procedure

1Therapeutics
02/2014